K
Krzysztof Dyrbuś
Researcher at University of Silesia in Katowice
Publications - 22
Citations - 458
Krzysztof Dyrbuś is an academic researcher from University of Silesia in Katowice. The author has contributed to research in topics: Medicine & Coronary artery disease. The author has an hindex of 7, co-authored 18 publications receiving 300 citations. Previous affiliations of Krzysztof Dyrbuś include Medical University of Silesia.
Papers
More filters
Journal ArticleDOI
Usefulness of atorvastatin in patients with heart failure due to inflammatory dilated cardiomyopathy and elevated cholesterol levels.
Romuald Wojnicz,Krzysztof Wilczek,Ewa Nowalany-Kozielska,Bożena Szyguła-Jurkiewicz,Jolanta Nowak,Lech Poloński,Krzysztof Dyrbuś,Arkadiusz Badziński,Gabriela Mercik,Marian Zembala,Jan Wodniecki,Marius M. Rozek +11 more
TL;DR: It is demonstrated that treatment with atorvastatin in addition to standard therapy for heart failure may significantly improve clinical outcomes in this cohort of patients.
Journal ArticleDOI
Inclisiran-New hope in the management of lipid disorders?
Krzysztof Dyrbuś,Mariusz Gąsior,Peter E. Penson,Kausik K. Ray,Maciej Banach,Maciej Banach,Maciej Banach +6 more
TL;DR: Inclisiran represents an entirely new mechanism of PSCK9 protein inhibition in hepatocytes, targeting the messenger RNA for PCSK9, and its administration is necessary only every 3 to 6 months, which is an essential advantage over statin and monoclonal antibody therapy.
Journal ArticleDOI
Red cell distribution width is associated with long-term prognosis in patients with stable coronary artery disease
Tadeusz Osadnik,Joanna Katarzyna Strzelczyk,Michał Hawranek,Andrzej Lekston,Jarosław Wasilewski,Anna Kurek,Aleksander Rafał Gutowski,Krzysztof Wilczek,Krzysztof Dyrbuś,Marek Gierlotka,Andrzej Wiczkowski,Mariusz Gąsior,Andrzej Szafranek,Lech Poloński +13 more
TL;DR: Higher RDW values correspond to higher comorbidity burdens and higher mortality, and RDW is an independent predictor of mortality in patients with stable coronary artery disease.
Journal ArticleDOI
PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021
Maciej Banach,Maciej Banach,Maciej Banach,Paweł Burchardt,Krzysztof Chlebus,Piotr Dobrowolski,Dariusz Dudek,Krzysztof Dyrbuś,Mariusz Gąsior,Piotr Jankowski,Jacek Jóźwiak,Longina Kłosiewicz-Latoszek,Irina Kowalska,Maciej T. Malecki,Aleksander Prejbisz,Michał Rakowski,Jacek Rysz,Bogdan Solnica,Dariusz Sitkiewicz,Grażyna Sygitowicz,Grazyna Sypniewska,Tomasz Tomasik,Adam Windak,Dorota Zozulińska-Ziółkiewicz,Barbara Cybulska +24 more
Journal ArticleDOI
Impact of chronic total occlusion artery on 12-month mortality in patients with non-ST-segment elevation myocardial infarction treated by percutaneous coronary intervention (From the PL-ACS Registry)
Marek Gierlotka,Mateusz Tajstra,Mariusz Gąsior,Michał Hawranek,Tadeusz Osadnik,Krzysztof Wilczek,Dawid Olszowski,Krzysztof Dyrbuś,Lech Poloński +8 more
TL;DR: The presence of CTO in non-IRA in patients with NSTEMI and 3-vessel coronary disease predicts higher 12-month mortality.